Head and neck cancer

Acta Oncologica

Volumn 35, Issue SUPPL. 7, 1996, Pages 22-45

  Möller, Torgil ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; HEAD AND NECK TUMOR; HUMAN; LARYNX TUMOR; LYMPH NODE METASTASIS; META ANALYSIS; PHARYNX CANCER; TONGUE TUMOR; TONSIL TUMOR;

HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; PHARYNGEAL NEOPLASMS; TONGUE NEOPLASMS; TONSILLAR NEOPLASMS;

EID: 0141529469     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841869609101661     Document Type: Article

References (424)

1. Janjan N, Campbell B, Wilson J, Toohill R. Radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: a review of recent techniques. Cancer Treat Rev 1990; 17: 89-101. (L1) (Pubitemid 20350467)
2. Vokes E. Weichselbaum R, Lippman S, Hong W, Head and neck cancer. N Engl J Med 1993; 328: 184-94. (L1)
3. Russel N, Bartelink H. Optimized radiotherapy for head and neck cancer. Curr Opin Oncol 1992; 4: 491-8. (L1)
4. Vokes E, Awan A, Weichselbaum R. Radiotherapy with concomitant chemotherapy for head and neck cancer. Hematol Oncol Clin North Am 1991; 5: 753-67. (L1)
5. Hamasaki V, Vokes E. Chemotherapy in head and neck cancer. Curr Opin Oncol 1992; 4: 504- 11, (L1)
6. Bataini J, Jaulerry C, Brunin F, Ponvert D, Ghossein N. Significance and therapeutic implications of tumor regression following radiotherapy in patients treated for squamous cell carcinoma of the oropharynx and pharyngolarynx. Head Neck 1990; 12: 41-9. (R1/1897) (Pubitemid 20027787)
7. Leibel S, Scott C, Mohiuddin M, Marcial V, Coia L, Davis L. Fuks Z. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys 1991; 21: 549-56. (R1/2648)
8. Tubiana M. The role of local treatment in the cure of cancer. Eur J Cancer 1992; 28A: 2061-9. (L1)
9. Maher EJ, Jefferis AF. Decision making in advanced cancer of the head and neck: variation in the views of medical specialists. J Royal SOC Med 1990; 83: 356-9, (O2) (Pubitemid 20234590)
10. Cachin Y, Eschwege F. Combination of radiotherapy and surgery in the treatment of head and neck cancers. Cancer Treat Rev 1975; 2: 177-91. (L2)
11. Fletcher GH, Jessee RH. The place of irradiation in the management of the primary lesion in head and neck cancers. Cancer 1977; 39: 862-7. (L2) (Pubitemid 8060277)
12. Fletcher G. Oral cavity and oropharynx. In: Textbook of Radiotherapy, 3rd ed. Philadelphia: Lean and Febiger. 1980: 286-329. (L1)
13. Pierquin B, Wilson JF, Chassagne D. Modern brachytherapy. New York: Masson, 1987: 87-168. (L2)
14. McCaffrey T. Head and neck cancer surgery. Curr Opin Oncol 1992; 4: 499-503. (L1)
15. Finlay PM, Dawson F, Robertson AG, Soutar DS, An evaluation of functional outcome after surgery and radiotherapy for intraoral cancer. Brit J Oral Maxillofac Surg 1992; 30:14-17. (P1/255)
16. Ridge J, Squamous cancer of the head and neck: Surgical treatment of local and regional recurrence. Sem Oncol 1993; 20: 419-29. (L1) (Pubitemid 23321468)
17. Keidan RD, Kusiak JF. Complications following reconstruction with the pectoralis major myocutaneous flap: The effect of prior radiation therapy. Laryngoscope 1992; 102: 521-4. (R3/40)
18. Marcial V, Pajak T, Kramer S, Davis L. Stetz J, Laramore G. Jacobs J, Al-Sarraf M, Brady L. Radiation Therapy Oncology Group (RTOG) studies in head and neck cancer. Semin Oncol 1988; 15: 39-60. (O2) (Pubitemid 18073030)
19. Dische S, Radiotherapy in the nineties. Increase in cure. decrease in morbidity. Acta Oncol 1992; 31: 501-11. (O1)
20. Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1972; 29: 1446-9. (R1/2044)
21. Bataini JP, Bernier J, Brugere J, Jaulerry C, Picco C, Brunin F. Natural history of neck disease in patients with squamous cell carcinoma of oropharynx and pharyngolarynx. Radiother Oncol 1985; 3: 245-55. (R1/1666) (Pubitemid 15112224)
22. Snow GB, Balm AJM, Arendse JW, et al. Prognostic factors in neck node metastasis. In: Larson DL, et al. eds. Cancer in the neck. Evaluation and treatment. New York: MacMillan. 1986: 53-63. (R2/736)
23. Ghouri AF, Zamora RL, Harvey JE, Spitznagel EL. Sessions DG. Epidermoid carcinoma of the oral cavity and oropharynx: Validity of the current AJCC staging system and new statistical tools for the prediction of subclinical neck disease. Otolaryngol Head Neck Surg 1993; 108: 225-32. (R1/531) (Pubitemid 23105775)
24. Marks JE, Devineni VR. Harvey J, Sessions DG. The risk of contralateral lymphatic metastases for cancers of the larynx and pharynx. Am J Otolaryngol 1992: 13: 34-9. (R1/846)
25. Fletcher GH. Elective irradiation of subclinical disease in cancers of the head and neck. Cancer 1972; 29: 1450-4. (L1)
26. Bataini J, Bernier J, Jaulerry C, Brunin F, Pontvert D. Impact of cervical disease and its definitive radiotherapeutic management on survival: experience in 2013 patients with squamous cell carcinomas of the oropharynx and pharyngolarynx. Laryngoscope 1990: 100: 7 16-23. (R1/2013) (Pubitemid 20222872)
27. Vandenbrouck C, Sancho-Gamier H, Chassagne D, Saravane D, Cachin Y. Micheau C, Elective versus therapeutic radical neck dissection in epidermoid carcinoma of the oral cavity. Cancer 1980; 46: 386-90. (C2/75) (Pubitemid 10085956)
28. Suarez C, Llorente JL. Nuriez F, Diaz C, Gomez J, Neck dissection with or without postoperative radiotherapy in supraglottic carcinomas. Otolaryngol Head Neck Surg 1993; 109: 3-9. (R2/302) (Pubitemid 23230607)
29. Varghese C, Sankaranarayanan R, Nair B. Nair M. Predictors of neck node control in radically irradiated squamous cell carcinoma of the oropharynx and laryngopharynx. Head Neck 1993; 15: 105-8. (R2/171) (Pubitemid 23066887)
30. Peters LJ, Goepfert H, Ang KK, et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 1993; 26: 3- 1 1. (C2/240) (Pubitemid 23137882)
31. Mancuso A. Cervical lymph node metastases: Oncological imaging and diagnosis. Int J Radiat Oncol Biol Phys 1984; 10: 411-3. (O1)
32. Korb L, Spaulding C, Constable W, The role of definitive radiation therapy in squamous cell carcinoma of the oral tongue. Cancer 1991 67: 2733-7. (R2/114)
33. Mendenhall W, Million R. Cassisi N. Elective neck irradiation in squamous cell carcinoma of the head and neck. HeadNeck Surg 1980; 3: 15-20. (R1/159) (Pubitemid 10052005)
34. Pukander J, Karhuketo T, Penttila M, Pertovaara H. Karma P, Radical surgery for lingual cancer. Clin Otolaryngol 1990; 15: 229-34. (R2/58) (Pubitemid 20318310)
35. Dearnaley D. Dardoufas C, A'Hearn R. Henk J. Interstitial irradiation for carcinoma of thc tongue and floor of mouth: Royal Marsden Hospital Experience 1970- 1986. Radiother Oncol 1991; 21: 183-92. (R1/149)
36. Benk V, Mazeron J, Grimard L. et al. Comparison of curietherapy versus external irradiation combined with curletherapy in stage II squamous cell carcinomas of the mobile tongue. Radiother Oncol 1990: 18: 339-47. (R2/110) (Pubitemid 20264679)
37. Lefebvre J, Coche-Dequeant B. Castelain B. Prevost B. Buisset E. Ton Van J, Interstitial brachytherapy and early tongue squamous cell carcinoma management. Head Neck 1990; 12: 232-6. (R2/341) (Pubitemid 20155003)
38. Mazeron J, Crook J, Benck V. et al. Iridium 192 implantation of TI and T? carcinomas of the mobile tongue. Int J Radiat Oncol Biol Phys 1990; 19: 1369-76. 1R2/166)
39. Montemaggi P, Smaniotto D. Morganti A. Luzi S, Conibined external beam irradiation and interstitial radiotherapy of Tl-T2 cancers of the mobile tongue and floor of mouth. Rays 1991; 16: 53-8. (R3/31)
40. Bachaud JM. Delannes M. Allouache N. et al. Radiotherapy of stage I and II carcinomas of the mobile tongue and/or floor of the mouth. Radiother Oncol 1994; 31: 199-206. (R2/94) (Pubitemid 24190497)
41. Schmidt-Ullrich R, Zwicker R, Wu A, Kelly K. Interstitial IR-192 implants of the oral cavity: the planning and construction of volume implants. Int J Radiat Oncol Biol Phys 1991; 20: 1079-85. (O1)
42. Henk JM. Treatment of oral cancer by interstitial irradiation using iridium-192. Br J Oral Maxillofac Surg 1992; 30: 355-9. (R2/67)
43. Wang C, Radiotherapeutic management and results of T1NO, T2NO carcinoma of the oral tongue: evaluation of boost techniques. Int J Radiat Oncol Biol Phys 1989; 17:287-91. (R2/142) (Pubitemid 19203074)
44. Hanks G, Kramer S, Diamond J, Herring D. Patterns of care outcome survey: national outcome data for six disease sites. Am J Clin Oncol 1982: 5: 349-53. (R1/669) (Pubitemid 12064493)
45. Padmanabhan T. Sankaranarayanan R, Krishnan Nair M. Evaluation of local control, survival and pattern of failure with radiotherapy in cancer of the tongue. Oncology 1990; 47: 121-3. (R2/105) (Pubitemid 20075549)
46. Leung T-W, Lee AWM, Chan DKK. Definitive radiotherapy for carcinoma of the oral tongue. Acta Oncol 1993; 32: 559-64. (R2/125) (Pubitemid 23319700)
47. Shibuya H, Hoshina M. Takeda M, Matsumoto S, Sdzuki S, Okada N. Brachytherapy for stage I & II oral tongue cancer: An analysis of past cases focusing on control and complications. Int J Radiat Oncol Biol Phys 1993; 26: 51-8. (R1/370) (Pubitemid 23137887)
48. Million R, Cassisi N, Clark J, Cancer of the head and neck. In: DeVita VT, Hellman S, Rosenberg SA. eds. Cancer. Principles and Practice of Oncology, 3rd edition. Philadelphia: Lippincott, 1989: 488-590. (Ll)
49. Lambin P, Haie-Meder C, Gerbaulet A, Chassagne D. Curietherapy versus external irradiation combined with curietherapy in stage II squamous cell carcinoma of the mobile tongue. Radiother Oncol 1992; 23: 55-6. (03)
50. Pernot M, Malissard L. Aletti P, Hoffstetter S, Forqard JJ, Bey P, Iridium-192 brachytherapy in the management of 147 T2NO oral tongue carcinomas treated with irradiation alone: comparison of two treatment techniques. Radiother Oncol 1992; 23: 223-8. (R2/147)
51. Bundgaard T, Tandrup O Elbrφnd O. A functional evaluation of patients treated for oral cancer. A prospective study. Int J Oral Maxillofac Surg 1993; 22: 28-34. (P1/87) (Pubitemid 23122455)
52. Wendt C, Peters L, Delclos L, Ang K, Morrison W, Maor M. Robbins K, Byers R, Carlson L, Oswald M. Primary radiotherapy in the treatment of stage I and II oral tongue cancers: importance of the proportion of therapy delivered with interstitial therapy: see comments. Int J Radiat Oncol Biol Phys 1990; 18: 1287-92. (R2/103) (Pubitemid 20234137)
53. Riessbeck K, Müller A, Rink B. Dalliige K. Below M. Die Ergebnisse der präoperativen Strahlentherapie des fortgeschrittenen Mundboden-Zungenkarzinomas. Radiobiol Radiother (Berlin) 1989; 30: 373-5. (C3/120) (Pubitemid 19221389)
54. Rink B. Neumann H, Kuchler I. Klinische Erfahrungen mit underschiedlichen Vorbestrahlungsmodi bei fortgeschrittenen Zungen-Mundbodenkarzinomen. Dtsch Z Mund Kiefer Gesichtschir 1989; 13: 286-90. (C2/90)
55. Mendenhall W, Parsons J, Stringer S, Cassisi N. Million R. T2 oral tongue carcinoma treated with radiotherapy: analysis of local control and complications. Radiother Oncol 1989: 16: 275-81. (R3/42) (Pubitemid 20015710)
56. Zelefsky M. Harrison L. Fass D. Armstrong J, Spiro R. Shah J, Strong E. Postoperative radiotherapy for oral cavity cancers: impact of anatomic subsite on treatment outcome. Head Neck 1990; 12: 470-5. (R1/51)
57. Dandapat MC, Mukherjee LM. Mishra SB. Kar NK. Management of oral cancer in late stages: A review. J Indian Med Assoc 1992; 90: 153-5. (R3/60)
58. Wazer D, Schmidt-Ulrich R, Keisch M, Karmody C, Koch W, The role of combined composite resection and irradiation in the management of carcinoma of the oral cavity and oropharynx. Strahlenther Onkol 1989; 165: 18-22. (R3/35) (Pubitemid 19027975)
59. Hall EJ, Brenner DJ, The dose-rate effect in interstitial brachytherapy: a controversy resolved. Br J Radiol 1992; 65: 242-7. (O2)
60. Mahe M, De Laroche G, Romestaing P, Marquis I Montbarbon X, Ardiet JM, Sentenac I, Gerard JP, An original technique of brachytherapy for T1 T2 carcinomas of the mobile tongue. Int J Radiat Oncol Biol Phys 1993; 25: 513-6. (P2/24) (Pubitemid 23068719)
61. Simon JM, Mazeron JJ, Pohar S, et al. Effect of intersource spacing on local control and complications in brachytherapy of mobile tongue and floor of mouth. Radiother Oncol 1993; 26: 19-25. (R2/274) (Pubitemid 23063605)
62. Spaulding C, Korb L, Constable W, Cantrell R, Levine P. The influence of extent of neck treatment upon control of cervical lymphadenopathy in cancers of the oral tongue. Int J Radiat Oncol Biol Phys 1991; 21: 577-81. (R2/84)
63. Hemprich A. M̈ller R. Long-term results in treating squamous cell carcinoma of the lip, oral cavity, and oropharynx. Int J Oral Maxillofac Surg 1989; 18: 39-42. (R2/352) (Pubitemid 19076709)
64. Fietkau R, Grabenbauer G. Iro H, Müller R, Farmand M, Atendorf-Hofmann A, Sauer R. Interstitiella und perkutane Strahlentherapie nach begrenzten chirurgischen Eingriffen beim Mundhohlenkarzinom. Strahlenther Onkol 1991; 167: 591-8. (L2)
65. 198Au grain implants in the treatment of oral and oropharyngeal cancer. Radiother Oncol 1991, 21: 29-38. (R2/177)
66. Mazeron J, Simon J, Le Pechoux C, Crook J, Grimard L. Piedbois P, Le Bourgeois J, Pierquin B. Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium-192. Radiother Oncol 1991; 21: 39-47. (R1/279)
67. Perez C, Brady L. Principles and practice of radiation oncology. 2nd ed. Philadelphia: JB Lippincott Co, 1992. (L1)
68. Jones AS, Khan H. The patterns and treatment of recurrence following radiotherapy for carcinoma of the oral cavity. Clin Otolaryngol 1993; 18: 14-18. (R2/186) (Pubitemid 23092604)
69. Teshima T, Inoue T, Chatani M. Hata K, Hiyama T, Ikeda H. Murayama S, Incidence of other primary cancers in 1569 patients with pharyngolaryngeal cancer and treated with radiation therapy. Strahlenther Onkol 1992; 168: 213-8. (R2/ 1569)
70. 2 cancers of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 1992; 24: 59-64. (R1/600)
71. Jaulerry C, Rodriques J, Brunin F, et a]. Results of radiation therapy in carcinoma of the base of the tongue. The Curie Institute experience with about 166 cases. Cancer 1991; 67: 1532-8. (R1/166)
72. Logemann JA. Pauloski BR, Rademaker AW, et al. Speech and swallow function after tonsil/base of tongue resection with primary closure. J Speech Hearing Res 1993; 36: 918-26. (P2/11) (Pubitemid 23299999)
73. Ausili-Cefaro G. Nardone L. Salvi G, Marmiroli L. Indications and results of combined external beam radiation and interstitial radiotherapy in the treatment of carcinoma of the oropharynx. Rays 1991; 16: 97-106. (L1)
74. Calais G. Reynaud-Bougnoux A, Bougnoux P, Le Floch O. Squamous cell carcinoma of the base of the tongue: results of treatment in 115 cases. Br J Radiol 1989: 62: 849-53. (R2/115) (Pubitemid 19229719)
75. Lusinchi A, Eskandari J, Son Y, et al. External irradiation plus curietherapy boost in 108 base of tongue carcinomas. Int J Radiat Oncol Biol Phys 1989; 17: 1191-7. (R2/108) (Pubitemid 20028635)
76. Mazeron J, Crook J, Martin M, Peynegre R, Pierquin B. Iridium 192 implantation of squamous cell carcinomas of the oropharynx. Am J Otolaryngol 1989; 10: 317-21. (R2/127) (Pubitemid 19261457)
77. Mazeron J-J, Belkacemi Y, Simon J-M. et al. Place of iridium 192 implantation in definitive irradiation of faucial arch squamous cell carcinomas. Int J Radiat Oncol Biol Phys 1993: 27: 251-7. (R2/165) (Pubitemid 23304450)
78. Sessions R, Harrison L. Strong E, Spiro R. A management plan for tongue base cancer that includes brachytherapy. Otolaryngol Head Neck Surg 1990; 103: 599-604. (O2) (Pubitemid 20360102)
79. Foote R. Parsons J. Mendenhall W, Million R. Cassisi N Stringer S, Is interstitial implantation essential for successful radiotherapeutic treatment of base of tongue carcinoma? Int J Radiat Oncol Biol Phys 1990; 18: 1293-8. (R2/84) (Pubitemid 20234138)
80. Harrison L, Sessions R, Strong E. Fass D, Nori D. Fuky Z. Brachytherapy as part of the definitive management of squamous cancer of the base of tongue. Int J Radiat Oncol Biol Phys 1989; 17: 1309-12. (R3/17) (Pubitemid 20028652)
81. Harrison LB. Zelefsky MJ, Sessions RB, et al. Base-oftongue cancer treated with external beam irradiation plus brachytherapy: Oncologic and functional outcome. Radiol 1992; 184: 267-70. (R3/36)
82. Mendenhall W, Parsons J, Mendenhall N. Million R. Brachytherapy in head and neck cancer: selection criteria and results at the University of Florida. Oncology (Williston Park) 1991; 5: 44-54. 59-60. (L2)
83. Marcial V, Hanky J, Hendrickson F. Ortiz H. Split-course radiation therapy of carcinoma of the base of the tongue: results of a prospective national collaborative clinical trial conducted by the Radiation Therapy Oncology Group, Int J Radiat Oncol Biol Phys 1983; 9: 437-43. (R2/141) (Pubitemid 13097079)
84. Tiwari R. Karim ABMF. Greven AJ, Snow GB. Total glossectomy with laryngeal preservation. Arch Otolaryngol Head Neck Surg 1993; 119: 945-9. (R3/26) (Pubitemid 23270398)
85. Housset M, Baillet F, Delanian S, et al. Split course interstitial brachytherapy with a source shift: the results of a new iridium implant technique versus single course implants for salvage irradiation of base of tongue cancers in 55 patients. Int J Radiat Oncol Biol Phys 1991; 20: 965-71. (R2/55)
86. Kob D. Quade R. Gramowski K. Zum Stellenweri der Strahlentherapie bei Pharynxkarzinomen. Radiobiol Radiother (Berl) 1989; 30: 331-7. (L2) (Pubitemid 19221377)
87. Pernot M. Baillet F. Tonsillar region. In: Pierquin B. Wilson JF. Chassagne D. eds. Modern brachytherapy. New York: Masson. 1987: 141-5. (L2)
88. Singh AM, Bahadur S, Tandon DA, Pande RM. Anterior mandibulotomy for oral and oropharyngeal turnours. J Laryngol Otol 1993; 107: 316-9. (R3/39) (Pubitemid 23173293)
89. Lee WR, Mendenhall WM. Parsons JT. Million RR. Cassisi NJ, Stringer SP, Carcinoma of the tonsillar region: A multivariate analysis of 243 patients treated with radical radiotherapy. Head Neck 1993; 15: 283-8. (R2/243) (Pubitemid 23174890)
90. Calais G, Chauvet B. Garand G. Beutter P, Reynautl-Bougnoux A. Le Floch O. Cancers de la region amygdalienne. Place de I'irradiation dans le traitement. Ann Radiol (Paris) 1989; 32: 555-9. (R2/137) (Pubitemid 20142449)
91. Calais G, Gaga D, Garand G, Beutter P, Lo Floch O.Radiotherapie des carcinomes de I'oropharynx. Resultats de 10 ans d'experience au CHU de Tours. Rev Stomatol Chir Maxillofac 1989; 90: 24-9. (R9/305)
92. Lusinchi A. Wibault P, Marandas P, Kunkler I. Eschwege F. Exclusive radiation therapy: the treatment of early tonsillar tumors. Int J Radiat Oncol Hiol Phys 1989; 17: 273-7. (R2/93) (Pubitemid 19203072)
93. Wong C, Ang K. Fletcher G. et al. Definitive radiotherapy for squamous cell carcinoma of the tonsillar fossa. Int J Radiat Oncol Biol Phys 1989: 16: 657-62. (R2/150) (Pubitemid 19079701)
94. Di Marco A. Rirzotti A. Grandinetti A. Campostrini F. Palazzi M. Garusi G. External radiotherapy in the treatment of tonsillar carcinomas. Analysis of 183 cases. Tumori 1990; 76: 244-9. (R2/183) (Pubitemid 20332816)
95. Gehanno P, Depondt J, Guedon C, Kebaili C, Koka V. Primary and salvage surgery for cancer of the tonsillar region: A retrospective study of 120 patients. Head Neck 1993; 15: 185-9. (R2/120) (Pubitemid 23122098)
96. Kajanti M, Mantyla M. Squarnous cell carcinoma of the tonsillar region. A retrospective analysis of treatment results. Acta Oncol 1991; 30: 629-33. (R3/75)
97. Perez C, Carmichael T, Devineni V. et al. Carcinoma of the tonsillar fossa: a nonrandomized comparison of irradiation alone or combined with surgery: long-term results. Head Neck 1991; 13: 282-90. (R2/296)
98. Lindelliv B. Monberg J, Hansen HS, Squamous cell carcinoma of the oropharynx. Results of primary radiotherapy. Acta Oncol 1992; 31: 341-5. (R2/226)
99. Pernot M, Malissard L. Taghian A. Hoffstetter S, Luporsi E. Forprd J-J, Aletti P, Bey P, Velotonsillar squamous cell carcinoma: 277 cases treated by combined external irradiation and brachytherapy results according to extension, localization, and dose rate. Int J Radiat Oncol Biol Phys 1992: 23: 715-23. (R2/277)
100. Kajanti MJ, Holsti LR. Mintyla MM. Postoperative radiotherapy of squamous cell carcinoma of the tonsil. Acta Oncol 1992; 31: 49-52. (R3/40)
101. O'Brien CJ, Castle GK. Stevens GN. Mac Halliday G. Donovan JK, Lee KK. Packham NA. Peat MJ, Limitations of radiotherapy in the definitive treatment of squamous carcinoma of the tonsillar fossa. Aust NZJ Surg 1992: 62: 709-13. (R2/104)
102. Thompson WM, Foote RL. Olsen KD. Schaid DJ, Grado GL. Buskirk SJ, Earle JD. Postoperative irradiation for tonsillar carcinoma. Mayo Clin Proc 1993; 68: 665-9. (R3/16) (Pubitemid 23193892)
103. Zelefsky MJ, Harrison LB. Arnistrong JG. Long-term treatment results of postoperative radiation therapy for advanced stage oropharyngeal carcinoma Cancer 1997: 70: 2388-95. (R2/5 1)
104. Kramer S, Gelber R. Snow J et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer. Final report of study 73-03 of the Radiation Therapy Oncology Group, Head Neck Surg 1987: 10: 19 30. (C2/277) (Pubitemid 19098977)
105. lnoue T, Inoue T, lkeda H. Teshima T. Murayama S, Yamazaki H, Otani M. Prognostic factor of radiotherapy for squamous cell carcinoma of oropharynx without clinically positive nodes. Strahlenther Onkol 1993: 169: 476-80. (R3/138) (Pubitemid 23253470)
106. Tiedemann R. Behandlungsresultate bei Plattenepithelkarnnomen der Mundhohlc und des Oropharynx. Auris Nasus Larynx 1989; 16: III -8. (R3/150)
107. Pinsolle J, Demeauv H. Coustal B. Siberchicot F. Caudry M. Maire J-P, Michelet F-X. Results of surgical treatment of T3 and T4 tumors of the oral cavity and oropharynx. Am J Surg 1992: 164: 587-91. (R9/99)
108. Johansen L, Overgaard J, Overgaard M, Birkler N, Fisker A. Squamous cell carcinoma of the oropharynx: an analysis of 213 consecutive patients scheduled for primary radiotherapy. Laryngoscope 1990; 100: 985-90. (R2/213) (Pubitemid 20301598)
109. Zelefsky MJ, Harrison LB, Fass DE, Armstrong JG, Shah JP, Strong EW, Postoperative radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: impact of therapy on patients with positive surgical margins. Int J Radiat Oncol Biol Phys 1992; 25: 17-21. (R2/102) (Pubitemid 23029768)
110. Bataini J, Asselain B, Jaulerry C, et al. A multivariate primary tumour control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region: clinical and treatment parameters as prognostic factors. Radiother Oncol 1989; 14: 265-77. (R1/465) (Pubitemid 19136179)
111. Fowler JF, Tanner MA, Bataini JP, Asselain B, Bernier J, Lave C, Further analysis of the time factor in squamous cell carcinoma of the tonsillar region. Radiother Oncol 1990; 19: 237-44. (O2) (Pubitemid 20369217)
112. Marcial VA, Pajak TF, Rotman M, Brady LW, Amato D. "Compensatedq split-course versus continuous radiation therapy of carcinoma of the tonsillar fossa. Am J Clin Oncol 1993: 16: 389-96. (C2/137)
113. Meyzd J, Towpik E. Surgical and cryosurgical salvage of oral and oropharyngeal cancer recurring after radical radiotherapy. Eur J Surg Oncol 1991: 17: 567-70. (R2/62)
114. Viani L, Dammeijer P, Jones A, Dalby J, Stell P, Recurrence of oropharyngeal carcinoma after radiotherapy. J Laryngol Otol 1991; 105: 24-8. (R2/221)
115. Kaasa S, Kragh-Jensen E, Bjordal K, et al. Prognostic factors in patients with nasopharyngeal carcinoma. Acta Oncol 1993; 32: 531-6, (R2/122) (Pubitemid 23319695)
116. Sham J, Choy D. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma on local control and short-term survival. Head Neck 1991; 13: 298-310. (R1/262)
117. Liu T. Recent developments in diagnosis and treatment of nasopharyngeal carcinoma. Keio J Med 1991; 40: 59-62. (L2)
118. Leung S, Tsao S, Teo P, Foo W, Cranial nerve involvement by nasopharyngeal carcinoma: Response to treatment and clinical significance. Clin Oncol 1990; 2: 138-41. (R2/66)
119. Reinfuss M, Skoyszewski J, Radkowski A. Poorly differentiated naso- and oropharyngeal carcinoma. A retrospective comparison between the results of radiotherapy alone and radiotherapy plus adjuvant methotrexate. Acta Oncol 1991; 30: 39-43. (R2/141)
120. Roth S, Sack H, Bertram G. Strahlentherapeutische Technik und Ergebnisse beim Nasopharyngxkarzinom an den Kölner Universitätskliniken von 1974 bis 1985. Strahlenther Onkol 1989; 165: 633-40. (R2/76) (Pubitemid 19232994)
121. Kajanti M, Mantyla M. Carcinoma of the nasopharynx. A retrospective analysis of treatment results in 125 patients. Acta Oncol 1990: 29: 611-4. (R2/125) (Pubitemid 20294738)
122. Ingersoll L, Woo S, Donaldson S, et al. Nasopharyngeal carcinoma in the young: a combined MD Anderson and Stanford experience. Int J Radiat Oncol Biol Phys 1990: 19: 881-7. (R2/57) (Pubitemid 20345155)
123. Perez C, Devineni V, Marcial-Vega V, Marks J, Simpson J, Kucik N. Carcinoma of the nasopharynx: Factors affecting prognosis. Int J Radiat Oncol Biol Phys 1992: 23: 271-80. (R1/143)
124. Lee AWM, Law SCK, Foo W, et al. Nasopharyngeal carcinoma: local control by megavoltage irradiation. Br J Radiol 1993; 66: 528-36. (R1/4128) (Pubitemid 23185747)
125. Belgadi B. Richaud P, Lagarde P, et al. Radiotherapie des carcinomes du nasopharynx. Ann Otolaryngol Chir Cervicofac 1990; 107: 53-8. (R3/58) (Pubitemid 20116435)
126. Itami J, Anzai Y, Nemoto K, et al. Prognostic factors for local control in nasopharyngeal cancer (NPC): analysis by multivariate proportional hazard models. Radiother Oncol 1991; 21: 233-9. (R2/67)
127. Meyer P, Methlin G, Untereiner M. Resultats therapeutiques d'une série de 73 cas de carcinome naso-pharynge. Ann Otho-Laryng 1989; 106: 567-76. (R2/73) (Pubitemid 20068720)
128. Di Marco A, Pradella R, Campostrini F. Definitive irradiation of nasopharyngeal carcinoma: analysis of results and failures in 103 cases. Tumori 1991; 77: 343-9. (R2/103)
129. Bailet JW, Mark RJ, Abemayor E, et al. Nasopharyngeal carcinoma: Treatment results with primary radiation therapy. Laryngoscope 1992; 102: 965-72. (R2/103)
130. Chatani M, Matayoshi Y, Masaki N, et al. Radiation therapy of the nasopharyngeal carcinoma. Strahlenther Onkol 1993; 169: 527-33. (R2/89)
131. Chen W-Z, Zhou D-L, Luo K-SL. Long term observation after radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1989; 16: 311-4. (R2/323) (Pubitemid 19077189)
132. Sham J, Choy D. Prognostic factors of nasopharyngeal carcinoma: A review of 759 patients. Br J Radio 1990; 63: 51-8. (R1/759) (Pubitemid 20040216)
133. Chen C, Liu T, Zhao S, 10-year survival rate for patient with nasopharyngeal carcinoma after radiation therapy. Clinical analysis of 367 cases. Chin Med J 1989; 102: 239-42. (R3/367) (Pubitemid 19200347)
134. Lee A. Sham J, Poon Y, Ho J, Treatment of stage I nasopharyngeal carcinoma: analysis of the patterns of relapse and the results of withholding elective neck irradiation. Int J Radiat Oncol Biol Phys 1989; 17: 1183-90. (R1/196) (Pubitemid 20028634)
135. Lee A, Poon Y, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976- 1985: Overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992; 23: 261-70. (R1/5037)
136. Johansen LV, Mestre M, Overgaard J, Carcinoma of the nasopharynx: analysis of treatment results in 167 consecutively admitted patients. Head Neck 1992;14:200-7. (R2/167)
137. Teo P, Tsao S, Shiu W, et al. A clinical study of 407 cases of nasopharyngeal carcinoma in Hong Kong. Int J Radiat Oncol Biol Phys 1989; 17: 515-30. (R2/407) (Pubitemid 19227554)
138. Zhang Y, Liu T, Fi C, Intracavitary radiation treatment of nasopharyngeal carcinoma by the high dose rate afterloading technique. Int J Radiat Oncol Biol Phys 1989; 16: 315-8. (R2/64) (Pubitemid 19077190)
139. Wang C, Improved local control of nasopharyngeal carcinoma after intracavitary brachytherapy boost. Am J Clin Oncol 1991; 14: 5-8. (R2/146)
140. Yan J, Qin D, Hu Y, et al. Management of local residual primary lesions of nasopharyngeal carcinoma: Are higher doses beneficial? Int J Radiat Oncol Biol Phys 1989; 16: 1465-9. (R2/182) (Pubitemid 19154331)
141. Yan J, Xu G, Hu Y, et al. Management of local residual primary lesion of nasopharyngeal carcinoma: II. Results of prospective randomized trial on booster dose. Int J Radiat Oncol Biol Phys 1990: 18: 295-8. (C3/30) (Pubitemid 20097522)
142. Liu T. Trends in the clinical management of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1992; 23: 469-71. (L2)
143. Al-Sarraf M, Pajak T, Cooper J, Mohiuddin M, Herskovic A, Ager P, Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a radiation therapy oncology Group study. J Clin Oncol 1990; 8: 1342-51. (R3/26) (Pubitemid 20252306)
144. Fountzilas G, Danilidis J, Kosmidis P, et al. Platinum-based chemotherapy followed by radiation therapy of locally advanced nasopharyngeal cancer. A retrospective analysis of 39 cases. Acta Oncol 1991; 30: 831-4. (R3/39)
145. Bachouchi M, Cvitkovic E, Azli N, et al. High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin, and cisplatin before radiotherapy. J Natl Cancer lnst 1990; 82: 616-20. (R3/41) (Pubitemid 20115455)
146. Harrison L. Pfister D, Bosl G. Chemotherapy as part of the initial treatment for nasopharyngeal cancer. Oncology (Williston Park) 1991; 5: 67-70 (comments 70-71. 74. 79). ( L2)
147. Dimery IW, Peters LJ, Goepfert H, et al. Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma. J Clin Oncol 1993; 11 : 1919-28. (P2/47) (Pubitemid 23304617)
148. Azli N, Armand JP, Rahal M. Wibault P, Boussen H. Eschwege F, Schwaab G, Gasmi J, Bachouchi M. Cvitkovic E. Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type. Eur J Cancer 1992; 28A: 1792-7. (P2/30)
149. Rossi A, Molinari R, Boracchi P, et al. Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J Clin Oncol 1988; 6: 1401-10. (C1/229) (Pubitemid 19089028)
150. Turner SL, Tiver KW, Synchronous radiotherapy and chemotherapy in the treatment of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1993; 27: 371-7. (P2/43) (Pubitemid 23304464)
151. Tsao S, Shiu W, Radiotherapy and chemotherapy for nasopharyngeal carcinoma. Ear Nose Throat J 1990: 69: 272-8. (L2) (Pubitemid 20192724)
152. Sumitsawan Y, Lorvidhaya V, Martin N. Carcinoma of the nasopharynx in Chiang Mai University Hospital: A review of 205 cases. J Med Assoc Thai 1990; 73: 450-7. (R2/205)
153. Tsao SY. Nasopharyngeal carcinoma-A review of radiotherapy techniques. Ann Acad Med 1993; 22: 638-45. (L2)
154. Tang S, Lin F, Chen M. Liaw C, Leung W, Hong J. Prognostic factors of nasopharyngeal carcinoma. A multivariate analysis. Int J Radiat Oncol Biol Phys 1990: 19: 1143-9. (R1/561)
155. Luo R. Tang Q, Huang Y. Liao Y, Mou X. Hu Z. Coniparison of continuous and split-course radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1989; 16: 307-10. (R2/1882) (Pubitemid 19077188)
156. Mingchen Z. Results of radiotherapy in nasopharyngeal cancer. A retrospective comparison of split-course and continuous-course treatment schedules. Acta Oncol 1989; 18: 77-80. (R2/107)
157. Zhang E-P, Lian P-G, Cai K-L, Chen Y-F, Cai M-D. Zheng X-F, Guang X-X. Radiation therapy of nasopharyngeal carcinoma: Prognostic factors based on a 10-year follow-up of 1302 patients. Int J Radiat Oncol Biol Phys 1989: 16: 301-5. (R2/1302) (Pubitemid 19077187)
158. Wazer D. Schmidt-Ulrich R, Chasin W, Wu A. Buscher M. High-dose boost irradiation techniques for carcinoma of the nasopharynx. Am J Otolaryngol 1989; 10: 173-80. (O1) (Pubitemid 19135949)
159. Teo P, Tsao S, Leung S, Afterloading intracavitary radiation treatment of nasopharyngeal carcinoma, Description of a technique and preliminary treatment results. Acta Oncol 1989; 28: 525-7. (P2/73) (Pubitemid 19238876)
160. Erickson BA, Wilson JF. Nasopharyngeal brachytherapy. Am J Clin Oncol 1993; 16: 424-43. (L1) (Pubitemid 23301171)
161. Cooper J, Scott C, Marcial V. Griffin T. Fazekas J, Laramore G. Hoffman A. The relationship of nasopharyngeal carcinomas and second independent malignancies based on the Radiation Therapy Oncology Group experience. Cancer 1991; 67: 1673-7. (R2/l21)
162. Kondziolka D, Lundsford L. Stereotactic radiosurgery for squamous cell carcinoma of the nasopharynx. Laryngoscope 1991; 101: 519-22. (O2)
163. Sham J, Wei W, Choy D, Ho C, Tai P, Choi P, Treatment of persistent and recurrent nasopharyngeal carcinoma by brachytherapy. Br J Radiol 1989; 62: 355-61. (P2/30) (Pubitemid 19088505)
164. Gao L, Xu G, Yin W, Yan J, Cai W, Gu X. Preliminary experience in HDR brachytherapy for 72 nasopharyngeal carcinoma patients. Chin Med J 1993: 106: 467-70. (R3/72)
165. Wei W, Sham J, Choy D. Ho C, Lam K. Split-palate approach for gold grain implantation in nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1990; 116: 578-82. (R3/23) (Pubitemid 20172541)
166. Choy D, Sham JST. Wei WI. Ho CM. Wu PM. Transpalatal insertion of radioactive gold grain for the treamtent of persistent and recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1993: 25: 505-12. (R3/43) (Pubitemid 23068718)
167. Boussen H, Cvitkovic E, Wendling J, Azli N. Bachouchi M. Mahjoubi R. Kalifa C, Wibault P, Schwaab G. Armand J. Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin. bleomycin, and fluorouracil. J Clin Oncol 1991: 9: 1675-81. (R3/49)
168. Lee AWM. Law SCK. Foo W, et al. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976- 1985: survival after local recurrence. Int J Radiat Oncol Biol Phys 1993: 26: 773-8 2(R1/891)
169. Bradley P, Survey of current management of laryngeal and hypopharyngeal cancer. J R Coll Surg Edinb 1989: 34: 197-200. (O2) (Pubitemid 19238509)
170. Chilla R, Nies J, Bieber J, Hypopharynxkarzinome und Radikaloperation-ein sinnvolles therapeutisches Vorgehen?. Laryngorhinootologie 1990: 69: 352-5. (R3/49) (Pubitemid 20246306)
171. Fein DA, Mendenhall WM. Parsons JT. Stringer SP, Cassisi NJ, Million RR. Pharyngeal wall carcinoma treated with radiotherapy: impact of treatment technique and fractionation. Int J Radiat Oncol Biol Phys 1993: 26: 751-7. (R2/99) (Pubitemid 23229829)
172. Timon C, Walsh M. Henneshy T. Surgical treatment of hypopharyngeal tumours. JR Coll Surg Edinb 1991: 36: 113-6. (R2/51)
173. Slotman BJ, Kralendonk JH. Snow GB, Tiwari RM. Karim ABMF. Surgery and postoperative radiotherapy and radiotherapy alone in T3-T4 cancers of the pyriform sinus. Acta Oncol 1994; 33: 55-60. (R7/54) (Pubitemid 24131687)
174. Kleinsasser O. Glanz H. Kimmich T. Zur Behandling der Karzinome des Sinus piriforniis. HNO 1989: 37: 460-4. (R2/62) (Pubitemid 19275841)
175. Pradhan S, Post-cricoid cancer: an overview. Semin Surg Oncol 1989: 5: 33I -6. (R2/383)
176. Hamby L, McGrath PC, Luce EA. Meeker W, Kenady DE. Optimizing primary treatment for advanced laryngeal and pyriform sinus carcinoma. Am J Surg 1992; 164: 629 33. (R3/80)
177. Daly N, Bachaud J, David J, Pessey J, Douchez J, Irradiation externe postoperatoire des epithelionias epidermoides dy larynx et de I'hypopharynx. Bull Cancer 1989: 76: 745-55. (R2/138) (Pubitemid 19241639)
178. Bataini JP, Brugere J, Jaulerry CH. Brunin F. Bernier J, Ghossein NA. Radiation treatment of lateral epilaryngal cancer. Prognostic factors and results. Am J Clin Oncol 1984: 7: 641-5. (R2/167) (Pubitemid 15126566)
179. Jones AS, The management of early hypopharyngeal cancer: primary radiotherapy and salvage surgery. Clin Otolaryngol 1992; 17: 545-9. (R2/175) (Pubitemid 23044997)
180. Malan JF, Sellars SL, Kranold D. A critical review of hypopharyngeal carcinomas-1975-1985. South Afr J Surg 1993; 31: 74-8. (R3/77)
181. Sailer S, Sherouse G. Chaney E, Rosenman J, Tepper J, A comparison of postoperative techniques for carcinomas of the larynx and hypopharynx using 3-D dose distributions. Int J Radiat Oncol Biol Phys 1991; 21: 767-77. (O2)
182. Guerrier B, Balmigere G, Daures J, Lallemant J, Guerrier Y. Cancer of the laryngeal vestibule. A retrospective study of 161 cases. Arch Otorhinolaryngol 1989; 246: 378-81. (R2/161) (Pubitemid 19277247)
183. DeSanto L. Early supraglottic cancer. Ann Otol Rhinol Laryngol 1990; 99: 593-7. (R2/94)
184. Nikolaou A, Daniilidis J, Fountzilas G. Kouloulas A, Sombolos K, Velegrakis G. Supraglottic laryngectomy: experience with 66 patients over 20 years. J Laryngol Otol 1993; 107: 813-6. (R2/66) (Pubitemid 23289735)
185. Mendenhall W, Parsons J, Stringer S, Cassisi N. Million R. The role of radiation therapy in laryngeal cancer. CA Cancer J Clin 1990; 40: 150-65. (L2) (Pubitemid 20153785)
186. Bataini JP, Ennuyer A, Poncet P, Ghossein NA. Treatment of supraglottic cancer by radical high dose radiotherapy. Cancer 1974; 33: 1253-62. (R2/218)
187. Zamora RL, Harvey JE, Sessions DG, Spitznagel EL. Clinical staging for primary malignancies of the supraglottic larynx. Laryngoscope 1993; 103: 69-77. (R1/520) (Pubitemid 23028808)
188. Devineni V. Simpson J, Sessions D, Spector J, Hayden R, Fredrickson J, Fineberg B. Supraglottic carcinoma: impact of radiation therapy on outcome of patients with positive margins and extracapsular nodal disease. Laryngoscope 1991; 101: 767-70. (R2/79)
189. 2 laser. Laryngoscope 1983; 93: 429-32. (P3/20) (Pubitemid 13117263)
190. Barthes M, Bolla M. Lavieille J, Bensoussan S, Junien-Lavillauroy C, Les cancers du vestibule larynge: resultats et indications therapeutiques a propos de 124 cas. Rev Laryngol Otol Rhinol (Bord) 1990; 111: 45-9. (R2/124) (Pubitemid 20165883)
191. Shimm D, Coulthard S, Radiation therapy for squamous cell carcinoma of the supraglottic larynx. Am J Clin Oncol 1989: 12: 17-23. (R2/65) (Pubitemid 19037245)
192. Inoue T. Matayoshi Y, Inoue T, Ikeda H, Teshima T, Murayama S, Prognostic factors in telecobalt therapy for early supraglottic carcinoma. Cancer 1993; 72: 57-61. (R2/100) (Pubitemid 23182050)
193. McLean M. Primary management of limited laryngeal cancer by radiotherapy and surgical salvage: results of 164 cases treated in a district hospital. Clin Oncol (R Coll Radiol) 1989; 1 : 97-100. (R2/164)
194. Croll G, Gerritsen G, Tiwari R. Snow G. Primary radiotherapy with surgery in reserve for advanced laryngeal carcinoma. Results and complications. Eur J Surg Oncol 1989; 15: 350-6. (R2/58) (Pubitemid 19212518)
195. Wang M. Lavey R. Calcaterra T. Efficacy and morbidity of partial laryngectomy and postoperative radiation therapy. Laryngoscope 1990; 100: 1146 - 51. ( R3/24)
196. Wang C, Montgomery W, Deciding on optimal management of supraglottic carcinoma. Oncology (Huntingt) 1991; 5: 41 -6 (discussion 49. 53). (O2)
197. van Acht M. Hermans J, DolsmaW, Hulshof J, Leer J. Glottic and supraglottic carcinoma: a retrospective comparison of radiotherapy alone with sandwich therapy in 366 patients. Radiother Oncol 1989; 14: 103- 12. (R2/366) (Pubitemid 19055817)
198. Mendenhall W, Parsons J, Stringer S, Cassisi N, Million R. Carcinoma of the supraglottic larynx: a basis for comparing the results of radiotherapy and surgery. Head Neck 1990; 12: 204-9. (R2/129) (Pubitemid 20154999)
199. Schwerdtfeger F, Dornoff W, Gosepath J, Behandlungsresultate nach supraglottischer Kehlkopfteilresektion bei Karzinomen des Larynxeingangs, des Zungengrundes und des Hypopharynx. 2. Teil: Bestrahlungstherepie und Spatresultate nach chirurgisch-radiol. Laryngorhinootologie 1991; 70: 307-11. (R2/110)
200. Fietkau R, Sauer R. Moglichkeiten und Grenzen der Radiotherapie des Larynxkarzinoms. Strahlenther Onkol 1992; 168: 1-16. (L1)
201. Inoue T, Inoue T, Ikeda H, et al. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy. Strahlenther Onkol 1993; 169: 584-9. (R2/338) (Pubitemid 23327337)
202. Bradley P, Morgan D. Radiotherapy of advanced laryngeal cancer using three small fractions daily. Otolaryngol Head Neck Surg 1991; 104: 838-41. (P1/26)
203. Wendt C, Peters L, Ang K, Morrison W, Maor M, Goepfert H. Oswald M. Hyperfractionated radiotherapy in the treatment of squamous cell carcinomas of the supraglottic larynx. Int J Radiat Oncol Biol Phys 1989; 17: 1057-62. (P2/41) (Pubitemid 19279511)
204. Shaw H. Role of partial laryngectomy after irradiation in the treatment of laryngeal cancer: a view from the United Kingdom. Ann Otol Rhinol Laryngol 1991; 100(4 Pt 1): 268-73. (R2/118)
205. Lindelov B, Hansen H. Advanced squamous cell carcinoma of the larynx. Acta Oncol 1990; 29: 505-8. (R2/676) (Pubitemid 20262597)
206. O'Sullivan BO, Mackillop W, Gilbert R, Gaze M, Lundgren J, Atkinson C, Wynne C, Fu H. Controversies in the management of laryngeal cancer: results of an international survey of patterns of care. Radiother Oncol 1994; 31: 23-32. (O1)
207. Fernberg J, Ringborg U, Silfversward C, Ewert G, Haglund S, Schiratzki H, Strander H. Radiation therapy in early glottic cancer. Analysis of I77 consecutive cases. Acta Otolaryngol (Stockh) 1989; 108: 478-81. (R3/177) (Pubitemid 19277466)
208. MacLeod P, Daniel F. The role of radiotherapy in in-situ carcinoma of the larynx. Int J Radiat Oncol Biol Ph; 1990 18: 113-7. (R2/91) (Pubitemid 20047398)
209. Smith R, Lockey M. Carcinoma in situ and T, squamous cell carcinoma of the glottis: The Mississippi Baptist Medical Center experience. J Miss State Med Assw 1989; 30: 365-70. (R2/62)
210. Murty GE, Diver JP, Bradley PJ, Carcinoma in situ of the glottis: radiotherapy or excision biopsy? Ann Otol Rhinol Laryngol 1993; 102: 592-5. (R3/37) (Pubitemid 23236705)
211. Fein DA, Mendenhall WM. Parsons JT, Stringer SP, Cassisi NJ, Million RR. Carcinoma in situ of the glottic larynx: the role of radiotherapy. Int J Rddiat Oncol Biol Phys 1993: 27: 379-84. (R2/19) (Pubitemid 23304465)
212. Small W, Mittal BB, Brand WN, et al. Role of radiation therapy in the management of carcinoma in situ of the larynx. Laryngoscope 1993; 103: 663-7. (R3/21) (Pubitemid 23168217)
213. Flentje M, Wannenmacher M. Strahlentherapie des Keh- Ikopfkarzinoms. Radiologe 1991; 31: 332-8. (L1)
214. Kelly M, Hahn S, Spaulding C, Kersh C, Constable W,Cantrell R. Definitive radiotherapy in the management of stage I and II carcinomas of the glottis. Ann Otol Rhinol Laryngol 1989; 98: 235-9. (R2/187) (Pubitemid 19093126)
215. Pellitteri P, Kennedy T, Vrabec D, Beiler D. Hellstrom M. Radiotherapy. The mainstay in the treatment of early glottic carcinoma. Arch Otolaryngol Head Neck Surg 1991; 117: 297-301. (R1/185)
216. Robson N, Oswal V, Flood L. Radiation therapy of laryngeal cancer: a twenty year experience. J Laryngol Otol 1990; 104: 699-703. (R2/286) (Pubitemid 20311221)
217. Schwerdtfeger F, Dornoff W, Gosepath J, Die primär- kurative Strahlentherapie kleiner Stimmbandkarzinome. Eine Langzeitstudie mit Verlaufsbeobachtungen: Über 2 his 14 Jahre. Laryngorhinootologie 1990; 69: 308-11. (R2/92) (Pubitemid 20245179)
218. Daniilidis J, Nikolaou A. Symeonidis V. Our experience in the surgical treatment of TI carcinoma of the vocal cord. J Laryngol Otol 1990; 104: 222-4. (R2/94) (Pubitemid 20097679)
219. Glanz H. Kimmich T, Eichhorn T. Kleinsasser O. Behandlungsergebnisse bei 584 Kehlkopfcarcinomen an der Hals-Nasen-Ohrenklinik der Universitat Marburg. HNO 1989: 37: 1-10. ( R2/584) (Pubitemid 19041056)
220. Ton-Van J, Lefebvre J, Stern J, Buisset E, Coche-Dequeant B. Vankemmel B. Comparison of surgery and radiotherapy in TI and T2 glottic carcinomas. Am J Surg 1991; 162: 337-40. (R3/356)
221. Kowalski LP, Batista MBP, Santos CR, et al. Prognostic factors in glottic carcinoma clinical stage I and II treated by surgery or radiotherapy. Am J Otolaryngol 1993: 14: 122-7. (R2/145) (Pubitemid 23077347)
222. Myssiorek D. The role of surgery in early stage glottic carcinoma. Cancer Invest 1992; 10: 391-8. (L1)
223. Olsen KD, Thomas JV, Desanto LW, Suman VJ, Indications and results of cordectomy for early glottic carcinoma. Otolaryngof Head Neck Surg 1993; 108: 277-82. (R2/95) (Pubitemid 23105783)
224. Stalpers L. Verbeek A, van Daal W, Radiotherapy or surgery for T2NOMO glottic carcinoma? A decision-analytic approach. Radiother Oncol 1989; 14: 209-17. (O1) (Pubitemid 19087088)
225. Zablow A. Erba P, Sanfillippo L. Radiotherapy T? glottic carcinoma. N J Med 1989; 86: 879-82. (R2/63)
226. Mendenhall WM. Parsons JT. Million RR. Management of TI and T2 squamous cell carcinoma of the glottic larynx. Mayo Clin Proc 1992; 67: 703-5. (R2/304)
227. Million RR. Carcinomas of the larynx and hypopharynx. Meyer JL Vaeth JM. eds: Organ Conservation in Curative Cancer Treatment. Front Radiat Ther Oncol. Baser Karger 1993: 27: 31-40. (L2)
228. Hoyt DJ, Lettinga JW, Leopold KA. Fisher SR. The effect of head and neck radiation therapy on voice quality. Luryngoscope 1992; 102: 477-80. (P2/25)
229. Tsuji D. Fukuda H. Kawasaki Y, Kawaida M. Kaniaki J, A clinical study on T1 glottic cancer treated by laser technique. Keio J Med 1989; 38: 413-8. (R3/40)
230. Epstein B, Lee D, Kashima H, Johns M. Stage T1 glottic carcinoma: results of radiation therapy or laser excision. Radiology 1990: 175: 567-70. (R2/77) (Pubitemid 20135304)
231. Cragle SP, Brandenburg JH. Laser cordectomy or radiotherapy: cure rates, communication and cost. Otolaryngol Head Neck Surg 1993: 108: 648-54. (M2/3499) (Pubitemid 23199383)
232. Eckel HE. Thumfart WF. Laser surgery for the treatment or larynx carcinomas: indications. techniques and preliminary results Ann Otol Rhino1 Laryngol 1992: 101: 113-8 (R2/110)
233. Cellai E. Chiavacci A. Olmi P, Causes of failure of curative radiation therapy in 205 early glottic cancers. Int.I Radial Oncol Biol Phys 1990; 19: 1139-42. (R2/205)
234. Turner S, Tiver K. Radical radiotherapy for carcinoma of the larynx- Westmead Hospital experience Austr Kadiol 1991. 35: 242-7. (R2/141)
235. Teshima T. Chatani M. Inoue T. Radiation therapy for early glottic cancer (TINOMO): I. Results of conventionail open field technique. Int J Radiat Oncol Biol Phys 1989; 17: 1199-202. (R2/91) (Pubitemid 20028636)
236. Johansen L. Overgaard J, Hjelm-Hansen M. Gadeberg C. Primary radiotherapy of TI squamous cell carcinoma of the larynx: analysis of 478 patients treated from 1963 to 1985. Int J Radial Oncol Biol Phys 1990: 18: 1307-13. (R2/478) (Pubitemid 20234140)
237. Lustig R. Krall J, Curran W, Hanks G. Improvements observed in care and outcome in carcinoma of the larynx. Int J Radial Oncol Biol Phys 1991. 20 101-4. (R2/521)
238. Terhaard C, Snippe K. Ravasz L. van der Tweel I. Hordijk G. Radiotherapy in T, laryngeal cancer: Prognostic rdctors for locoregional control and survival. uni- and multivariate analysis. Int J Radiat Oncol Biol Phys 1991: 21: 1179-86. (R1/194)
239. Stein M. Rosenblatt E. Kuten A. Cohen Y. Results of radiation therapy in early glottic carcinoma (TI, T2 NO). J Surg Oncol 1989; 40: 173-6 (R3/60) (Pubitemid 19078764)
240. Turesson I. Sandberg N. Merche C, Johansson K. Sandin I. Wallgren A. Primary radiotherapy for glottic laryngeal carcinoma stage I and II. A retrospective study with special regard to failure patterns. Acta Oncol 1991: 30: 357-62. (R2/302)
241. Chatani M, Matayoshi Y. Masnki N. Radiation therapy fur larynx carcinoma: long-term rcsults of stage I glottic carcinoma. Strahlenther Onkol 1993; 169: 102-6. (R2/95) (Pubitemid 23116644)
242. De Schryver A. Radiotherapy of laryngeal cancer. General principles and results in TI and T2 cases. Acta Oto-rhinolaryngol Belg 1992; 46: 187-95. (L2)
243. Small W, Mittal BB, Brand WN. et al. Results of radiation therapy in early glottic carcinoma: multivariate analysih of prognostic and radiation therapy variables. Radiol 1992; 183: 789-94. (R1/103)
244. Lusinchi A. Dube P, Wibault P, Kunkler I. Luboinski B, Eschwege F. Radiation therapy in the treatment of early glottic carcinoma: the experience of Villejuif. Radiother Oncol 1989; 15: 313-9. (R2/197) (Pubitemid 19218051)
245. Kob D. Quade K. Gramowski K. Haas D Ergehnisse der operativ- radiologtschen Behandlungsstrategie bei Larynxkarzinomen in Jenaer Patientenmaterial von 1964 his 1981. Radiobiol Radiother 1989: 30: 31-8. (R2/452) (Pubitemid 19070638)
246. Trassera J, Avellaneda R. Cuchi A. Arias C. Caracétristiques évolutives du cancer glottique. Ann Oto Laryng 1989: 106: 91-6. (R2/302)
247. lnoue T. Inoue T. lkeda H. Teshinia T. Murayama S. Prognostic Factor of telecobalt therapy for early glottic carcinoma. Cancer 1992; 70: 2797-801. (R2/330)
248. Rucci L. Gallo O. Fini-Storchi O. Glottic cancer involving anterior commissure: surger? vs radiotherapy. Head Neck 1991; 13: 403-10 (R3/182)
249. Zohar Y. Rahima M. Shvili Y. Talmi Y. Lurk H. The controversial treatment of anterior coniniissurc carcinonia of the larynx. Laryngoscope 1992. 102: 69 -72. (R7/67)
250. Stevenson J, Juillard G. Selch M. Stages 1 and 2 epidermoid carcinoma or the glottic larynx incolvement or the anterior commissure. Radiology 1992: 182: 197-9 (R3/55)
251. Vermund H. Boyscn M. Brandenburg J, et al. Primary irradiation. surgcry or comhined therap! in squanious cell carcinoma of the laryrix. A comparison of treatment rehults from two centers. Acta Oncol 1990; 29: 489-503. (Rl/730) (Pubitemid 20262596)
252. Sandberg N. Mercke C, Turesson I Glottic laryngcal carcinoma with fixed vocal cord treated with full-dose radiation. total laryngectomy or combined treatment ActaOncol 1990: 29: 509-11. ( R3/46) (Pubitemid 20262598)
253. Guiney M. Smith J, Hughch P, Narayan K Radiation therapy of glottic carcuionu. Pcter MacC'allum ('ancer Institute experience. Aust N Z J Surg1992: 62. 622-7. (R2/l27)
254. 3, carcinoma of the larynx by surgery or radiotherapy. Clin Otolaryngol 1992; 17: 433-6. (R2/147)
255. Rockley T, Robin P, Powell J, McConkey C, Primary treatment of cancer of the larynx. J Laryngol Otol 1991; 105: 459-62. (R1/3445)
256. Reddy KTV, Vinayak BC, Jefferis AF, Wallace M. Primary radiotherapy for treating all laryngeal cancer: a district hospital experience. J Laryngol Otol 1993: 107: 454-6. (R3/85)
257. Lee WR, Mancuso AA, Saleh EM, Mendenhall WM, Parsons JT, Million RR. Can pretreatment computed tomography findings predict local control in T3 squamous cell carcinoma of the glottic larynx treated with radiotherapy alone? Int J Radiat Oncol Biol Phys 1993; 25: 683-7. (R2/29) (Pubitemid 23099263)
258. Levendag PC, Ravasz LA, Terhaard CHJ, Hordijk GJ, T3 squamous cell carcinoma of the larynx treated by a splitcourse radiation protocol. Am J Clin Oncol 1993; 16: 509-18. (R2/131) (Pubitemid 24004104)
259. Tennvall J, Wennerberg J, Willen R, Ask A, Baldetorp B, Fernö M. T3NO glottic carcinoma: DNA S-phase as a predictor of the outcome after radiotherapy. Acta Otolaryngol (Stockh) 1993; 113: 220-4. (R2/23) (Pubitemid 23084749)
260. Terhaard C, Karim A, Hoogenraad W, et al. Local control in T3 laryngeal cancer treated with radical radiotherapy, time dose relationship: the concept of nominal standard dose and linear quadratic model. Int J Radiat Oncol Biol Phys1991; 20: 1207-14. (R2/104)
261. 2, larynx cancer. Radiother Oncol 1990; 18: 321-7. (R2/75) (Pubitemid 20264677)
262. Cano E, Flickinger J, Johnson J, Multivariate analysis results of radiotherapy for laryngeal cancer. Head Neck 1993; 15: 382-8. (R3/80) (Pubitemid 23239838)
263. Inoue T, Inoue T, Chatani M, Teshima T. Irradiated volume and arytenoid edema after radiotherapy for TI glottic carcinoma. Strahlenther Onkol 1992; 168: 23-6. (C3/116)
264. Krawczyk J, Svoboda V, Foster L. The influence of some factors on local control of early glottic cancer. Clin Oncol (R Coll Radiol) 1991; 3: 330-4. (R1/122)
265. Lindelov B, Lauritzen A, Hansen H. Stage I glottic carcinoma: an analysis of tumour recurrence after primary radiotherapy. Clin Oncol (R Coll Radiol) 1990; 2: 94-6. (R2/145)
266. Kim R, Marks M, Salter M. Early-stage glottic cancer: importance of dose fractionation in radiation therapy. Radiology 1992; 182: 273-5. (R2/85)
267. Rudoltz MS, Benammar A, Mohiuddin M. Prognostic factors for local control and survival in TI squamous cell carcinoma of the glottis. Int J Radiat Oncol Biol Phys 1993; 26: 767-72. (R1/91) (Pubitemid 23229831)
268. Fein DA, Mendenhall WM, Parsons JT. Million RR. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control. Int J Radiat Oncol Biol Phys 1993; 25: 605-11. (R1/247) (Pubitemid 23099252)
269. Izuno I, Sone S, Oguchi M, Kiyono K. Takei K. Treatment of early vocal cord carcinoma with 6Oco gamma rays, 8/10 MV x-rays, or 4 MV x-rays-are the results different? Letter. Acta Oncol 1990; 29: 637-9. (R2/245)
270. Hayakawa K, Mitsuhashi N, Tamaki Y, et al. Radiation therapy for stage I and II laryngeal cancer using 10 MV x-rays or Cobalt-60 rays. Radiat Med 1992; 10: 199-205. (R2/117)
271. Akine Y, Tokita N, Ogino T, et al. Radiotherapy of TI glottic cancer with 6 MeV x rays. Int J Radiat Oncol Biol Phys 1991; 20: 1215-8. (R2/154)
272. Foote RL, Olsen KD, Kunselman SJ, et al. Early-stage squamous cell carcinoma of the glottic larynx managed with radiation therapy. Mayo Clin Proc 1992; 67: 629-36. (R3/45)
273. Hammer J, Hochleitner F, Meindl J, Seewald D, Track C, Kundrath E. Kombinierte externe und interstitielle Radiotherapie des Stimmbandkarzinoms. Strahlenther Onkol 1991; 167: 277-81. (P2/16)
274. Balla M, Polyzoidis T. Die Radiumkontaktbestrahlung des Stimmbandkarzinoms-eine mogliche Behandlungsmethode?. Strahlenther Onkol 1990; 166: 132-4. (R3/113) (Pubitemid 20118089)
275. Kersh C, Kelly M, Hahn S, Spaulding C, Cantrell R, Constable W, Early glottic carcinoma: patterns and predictors of relapse after definitive radiotherapy: see comments. South Med J 1990; 83: 374-8. (R1/148) (Pubitemid 20143690)
276. Parsons J, Mendenhall W, Mancuso A, Cassisi N, Stringer S, Million R. Twice-a-day radiotherapy for T3 squamous cell carcinoma of the glottic larynx. Head Neck 1989; 11: 123-8. (P2/21) (Pubitemid 20044978)
277. Mendenhall WM, Parsons, JT, Stringer SP, Cassisi NJ, Million RR. Stage T3 squamous cell carcinoma of the glottic larynx: a comparison of laryngectomy and irradiation. Int J Radiat Oncol Biol Phys 1992; 23: 725-32. (R2/118)
278. Rothfield R, Johnson J, Myers E, Wagner R. Hemilaryngectomy for salvage of radiation therapy failures. Otolaryngol Head Neck Surg 1990; 103: 792-4. (R3/14)
279. Howell-Burke D, Peters L, Goepfert H, Oswald M. T2 glottic cancer. Recurrence, salvage, and survival after definitive radiotherapy. Arch Otolaryngol Head Neck Surg 1990; 116: 830-5. (R2/114) (Pubitemid 20218762)
280. Maipang T, Razack M, Sako K, Chen T. Surgical salvage for recurrent "early" glottic cancers. J Surg Oncol 1989; 40: 32-3. (R2/143) (Pubitemid 19039196)
281. Mendenhall W, Parsons J, Brant T, Stringer S, Cassisi N, Million R. Is elective neck treatment indicated for T2NO squamous cell carcinoma of the glottic larynx?. Radiother Oncol 1989; 14: 199-202. (R2/98) (Pubitemid 19087086)
282. Wang CC, McIntyre J, Re-irradiation of laryngeal carcinoma-techniques and results. Int J Radiat Oncol Biol Phys 1993; 26: 783-5. (R3/20)
283. Lavey R, Calcaterra T. Partial laryngectomy for glottic cancer after high-dose radiotherapy. Am J Surg 1991; 162: 341-4. (R3/25)
284. Crellin RP, Gaze MN, White A, Maran AGD, Macdougall RH. Salvage laryngectomy after radical radiotherapy for laryngeal carcinoma. Clin Otolaryngol 1992; 17: 449-51. (R3/56)
285. Viani L, Stell P, Dalby J, Recurrence after radiotherapy for glottic carcinoma. Cancer 1991; 67: 577-84. (R1/478)
286. McCombe AW, Jones AS, Radiotherapy and complications of laryngectomy. J Laryngol Otol 1993; 107: 130-2. (R2/357) (Pubitemid 23209054)
287. Razack M, Maipang T, Sako K, Bakamjian V, Shedd D. Management of advanced glottic carcinomas. Am J Surg 1989; 158: 318-20. (R2/128) (Pubitemid 19246231)
288. 2-laser treatment of recurrent glottic carcinoma. Clin Otolaryngol 1992; 17: 430-2. (R3/23)
289. Guedea F, Parsons J, Mendenhall W, Million R, Stringer S, Cassisi N. Primary subglottic cancer: results of radical radiation therapy. Int J Radiat Oncol Biol Phys 1991; 21: 1607- 11. (O3)
290. Haylock BJ, Deutsch GP, Primary radiotherapy for suhglottic carcinoma. Clin Oncol 1993; 5: 143-6. (R3/23)
291. Coia L, Calvin J, Sontag M, et al. Three-dimensional photon treatment planning in carcinoma of the larynx. Int J Radiat Oncol Biol Phys 1991; 21: 183-92. (O1)
292. Freeman D, Manusco A, Parsons J, Mendenhall W, Million R. Irradiation alone for supraglottic larynx carcinoma: can CT findings predict treatment results: see comments. Int J Radiat Oncol Biol Phys 1990; 19: 485-90, 497-8. (R2/54) (Pubitemid 20299046)
293. Karim A, Kralendonk J, Njo K. Tabak M, Gort G. A critical look at the TNM classification for laryngeal carcinoma. Cancer 1990; 65: 1918-22. (PI/564) (Pubitemid 20147628)
294. Kuchnir F. Heffron J, Myrianthopoulos L, Haraf D. Beam's-eye-view aided treatment planning for a nasopharyngeal lesion: a case report. Med Dosim 1989: 14: 231-5. (O2)
295. Kutcher G, Fuks Z, Brenner H, et al. Three-dimensional photon treatment planning for carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys 1991; 21: 169-82. (O2)
296. Kraiphibul P, Atichartakarn V. Treatment of nasopharyngeal carcinoma. J Med Assoc Thai 1992;75:435-44. (L1) (Pubitemid 23175239)
297. Koukourakis MI, Varveris HA, Helidonis ES, Gourtsogiannis NH. CT-based radiotherapy treatment planning for cancer of the nasopharynx. Comput Med Imaging Graph 1993; 17: 81-7. (R3/32) (Pubitemid 23254723)
298. Leibel S, Kutcher G. Harrison L, Fass D, Burman C, Hunt M, Mohan R, Brewster L, Ling C, Fuks Z. Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx. Int J Radial Oncol Biol Phys 1991; 20: 823-33. (O2)
299. Leibel S, Ling C, Kutcher G, Mohan R, Cordon-Cordo C. Fuks Z. The biological basis for conformal three-dimensional radiation therapy. Int J Radiat Oncol Biol Phys 1991; 21: 805-11. (O2)
300. Vijayakumar S, Low N, Chen G, et al. Beams eye viewbased photon radiotherapy I. Int J Radiat Oncol Biol Phys 1991; 21: 1575-86. (O1)
301. Esik O, Schlegel W, Boesecke R. Nmeth G. Lorenz W, Three-dimensional photon radiotherapy planning for laryngeal and hypopharyngeal cancers. I. Conventional rotational technique. Radiother Oncol 1991; 20: 229-37. (O2)
302. Esik O, Burkelbach J, Boesecke R, Schlegel W, Nemeth G. Lorentz WJ: Three-dimensional photon radiotherapy planning for laryngeal and hypopharyngeal cancers. Conformation treatment planning using a multileaf collimator. Radiother Oncol 1991; 20: 238-44. (O2)
303. LoSasso T, Chui CS, Kutcher GJ, Leibel SA, Fuks 2. Ling CC, The use of a multi-leaf collimator for confornial radiotherapy of carcinomas of the prostate and nasopharynx. Int J Radiat Oncol Biol Phys 1993; 25: 161-70. (03) (Pubitemid 23048768)
304. Lane R, Loyd M, Chow C, Ekwelundu E. Rosen I. Improved dose homogeneity in the head and neck using computer controlled radiation therapy. Int J Radial Oncol Biol Phys 1990; 19: 1531-8. (O2)
305. Keus R, Noach P, de Boer R, Lebesque J, The effect of customized beam shaping on normal tissue complications in radiation therapy of parotid gland tumors. Radiother Oncol 1991: 21: 211-7. (O1)
306. Kutcher G. Burman C, Brewster L. Goitein M, Mohan R. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radial Oncol Biol Phys 1991; 21: 137-46. (O1)
307. Niemierko A. Goitein M. Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical clement architecture. Radiother Oncol 1991; 20: 166-76. (O1)
308. Drzymala R. Mohan R, Brewster L. Chu J, Goitein M. Harms W, Urie M. Dose-volume histograms. Int J Radiat Oncol Biol Phys 1991: 21: 71 -78. (O2)
309. Mitine C, Leunens G. Verstraete J, et a]. Is it necessary to repeat quality control procedures for head and neck patients? Radiother Oncol 1991: 21: 210-10. (O1)
310. Hunt MA, Kutcher GJ, Burman C, et al. The effect of setup uncertainties on the treatment of nasopharynx cancer. Int J Radiat Oncol Biol Phys 1993: 27: 437-47. (O2) (Pubitemid 23304472)
311. Meertens H. Van Herk M. Bijhold J, Bartelink H. First clinical experience with a newly developed electronic portal imaging device. Int J Radiat Oncol Biol Phys 1990; 18: 1173-81. (O2) (Pubitemid 20182352)
312. Wade P, Nicholas D. Clinical application of an electronic imaging device for assisting patient set-up in radiotherapy. Br J Radiol 1991: 64: 596-602. (O1)
313. Slater JM. Slater JD. Archambeau JO. Carcinoma of the tonsillar region: Potential for use of proton beam therapy. Int J Radiat Oncol Biol Phys 1991; 22: 311-9. (O1)
314. Hayes J, Moeller J, Leavitt D. Davis R. Harnsberger H. Computed tomography treatment planning in IR-192 brachytherapy in the head and neck. Int J Radial Oncol Biol Phys 1992: 22: 181-9. (O1)
315. Hoshina M, Shibuya H. Horiuchi J, Matsubara S, Suzuki S. Takeda M. Discriminant analysis of the treatment results of interstitial radium tongue implants. Br J Radiol 1989: 62: 59-63. (O1) (Pubitemid 19026921)
316. Photon Treatment Planning Collaborative Workingng Group. State-of-the-art of external photon beam radiation treatment planning. Int J Radiat Oncol Biol Phys 1991; 21: 9-23. (O1)
317. Photon Treatment Planning Collaborative Workingng Group. Three-dimensional dose calculations for radiation treatment planning. Int J Radiat Oncol Biol Phys 1991: 21: 25-36. (O1)
318. Photon Treatment Planning Collaborative Working Group. Three-dimensional display in planning radiation therapy: a clinical perspective. Int J Radiat Oncol Biol Phys. 1991;21(1). 79-89. (O2)
319. Photon Treatment Planning Collaborative Workingng Group. The clinical three-dimcnsional treatment planning studies: a prologue. In1 J Radial Oncol Biol Phys 1991; 21: 165-7. (03)
320. Wiernik G. Alcock C, Bates T. et al. Final report of the second British Institute of Radiology fractionation study: short versus long overall treatment times for radiotherapy of carcinoma of the laryngo-pharynx. Br J Radiol 1991: 64: 232-41. (C2/734)
321. Parsons JT, Bova FJ, Million RR. A re-evaluation of splitcourse technique for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1980; 6: 1645-52. (R1/468) (Pubitemid 11137170)
322. Maciejewski B. Preuss-Bayer G. Trott K-R. The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys 1983: 9: 321-8. (R2/310)
323. Pajak T. Laramore G, Marcial V. et al. Elapsed treatment days-A critical item for radiotherapy quality control review in head and neck trials: RTOG report. Int J Radiat Oncol Biol Phys 1991: 20: 13-20. (M1/426)
324. van Putten WLJ, van der Sangen MJC, Hoekstra CJM. Levendag PC, Dose. fractionation and overall treatment time in radiation therapy-the effects on local control for cancer of the larynx. Radiother Oncol 1994; 30: 97-108. (R1/997) (Pubitemid 24101567)
325. 4 squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys 1991: 21: 813-7. (O1)
326. Rezvani M, Fowler JF, Hopewell JW, Alcock CJ, Sensitivity of human squamous cell carcinoma of the larynx to fractionated radiotherapy. Br J Radiol 1993; 66: 245-55. (O2) (Pubitemid 23096979)
327. Robertson AG, Robertson C, Boyle P, Symonds RP, Wheldon TE. The effect of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx. Eur J Cancer 1993; 29A: 501-10. (R2/336) (Pubitemid 23036294)
328. Maciejewski B, Withers H, Taylor J, Hliniak A. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation. Int J Radiat Oncol Biol Phys 1989; 16: 831-43. (R1/498) (Pubitemid 19079722)
329. Bentzen S, Johansen L, Overgaard J, Thames H. Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Rad Oncol Biol Phys 1991; 20: 1197-206. (R1/181)
330. Slevin N. Hendry J, Roberts S, Agren-Cronqvist A. The effect of increasing the treatment time beyond three 'weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. Radiother Oncol 1992: 24: 215-20. (R1/496)
331. Hendry JH, Roberts SA, Slevin NJ, Keane TJ, Barton MB.
332. Barton MB. Keane TI. Gadalla T, Maki E. The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer. Radiother Oncol 1992; 23: 137-43. (R1/1012)
333. Taylor JMG. Withers HR, Mendenhall WM. Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation. Radiother Oncol 1990: 17: 95-102. (O2) (Pubitemid 20062403)
334. Withers HR, Taylor JMG. Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988: 27: 131-46. (O1)
335. Fowler J, Rapid repopulation in radiotherapy: A debate on mechanism. The phantom of tumor treatment-continually rapid proliferation unmasked. Radiother Oncol 199 1 : 22: 156-8. (O2)
336. Bentzen S, Thames H. Clinical evidence for tumor clonogen regeneration: interpretations of the data. Radiother Oncol 1991: 22: 161-6. (O2)
337. Trott K. Kummermehr J, Rapid repopulation in radiotherapy: A debate on mechanism. Accelerated repopulation in tumours and normal tissues. Radiother Oncol 1991: 22: 159-60. (O2)
338. Maciejewski B, Zajusz A. Rota L. ROC analysis of benefit and limitation in radiotherapy for cancer of the oral cavity. Neoplasma 1993: 40: 181-4. (O2) (Pubitemid 23184013)
339. Fowler J, Apparent rates of proliferation of acutely responding normal tissues during radiotherapy of head and neck cancer. Int J Radkat Oncol Biol Phys 1991: 21: 1451-6. (O2)
340. Thames HD. Withers HR. Peters LJ, Fletcher GH. Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships. Int J Radiat Oncol Biol Phys 1982: 8: 219-26. (O1) (Pubitemid 12139897)
341. Taylor J, Mendenhall W, Lavey R. Dose time and fraction size issues for late effects in head and neck cancers. Int J Radiat Oncol Biol Phys 1992: 22: 3- 11. (R1/784)
342. Wiernik G, Bates T. Bleehen N. et al. Final report of the general clinical results of the British Institute of Radiology fractionation study of 3F/wk versus 5F/wk in radiotherapy of carcinoma of the laryngo-pharynx: see comments. Br J Radiol 1990; 63: 169-80, 315-6. (C2/734) (Pubitemid 20107266)
343. 2 carcinoma of the glottis: Relative hypofractionation. Radiol 1991; 179: 569-71. (R2/90)
344. Rezvani M, Alcock C, Fowler J, Haybittle J, Hopewell J, Wiernik G. Normal tissue reactions in the British Institute of Radiology Study of 3 fractions per week versus 5 fractions per week in the treatment of carcinoma of the laryngo-pharynx by radiotherapy. Br J Radiol 1991; 64: 1122-33. (C2/734)
345. Lee P, Hung B, Woo E, Tai P, Choi D. Effects of radiation therapy on neuropsychological functioning in patients with nasopharyngeal carcinoma. J Neurol, Neurosurg and Psychiatry 1989; 52, 488-92. (P1/16) (Pubitemid 19104507)
346. Lee AWM. Law SCK, Ng SH, et al. Retrospective analysis of nasopharyngeal carcinoma treated during 1976- 1985: late complications following megavoltage irradiation. Br J Radiol 1992; 65: 918-28. (R1/4527)
347. Weissberg J, Son Y. Percarpio B, Fischer J, Randomized trial of conventional versus high fractional dose radiation therapy in the treatment of advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1982: 8: 179-85. (C3/64) (Pubitemid 12139891)
348. Dinshaw K, Sharma V. Radiation therapy in early glottic carcinoma: significance of prognostic factors and dose fractionation. Indian J Cancer 1990; 27: 143-53. (R3/208)
349. Hadjieva T. Todorov J, Ivanova K. Some considerations based on preliminary results of twice a day irradiation of nasopharyngeal cancer. Radiobiol Radiother (Berl) 1989; 30: 346-50. (P2/18) (Pubitemid 19221381)
350. Medini E, Rao Y. Kim T, Jones T. Levitt S, Radiation therapy for advanced head and neck squamous-cell carcinoma using twice-a-day fractionation. Radiology 1980: 134: 531-2. (P2/15) (Pubitemid 10183113)
351. Parsons JT. Mendenhall WM. Cassisi NJ, Isaacs JH, Million RR. Hyperfractionation for head and neck cancer. Int J Radiat Oncol Biol Phys 1988; 14: 649-58. (R1/144)
352. Fallai C, Olmi P, Cellai E. Advanced carcinomas of the oropharynx treated with radiotherapy-a comparison of three different fractionation schemes. Am J Otolaryngol 1993; 14: 31-7. (R2/142) (Pubitemid 23057436)
353. Horiot J, Le Fur R, N'Guyen T. el al. Hyperfractionation versus conventional fractionation in oropharyngedl carcinoma: final analysis of a randomized trial of the EORTC cooperative Group of radiotherapy. Radiother Oncol 1992: 25: 231-41. (Cl/356) (Pubitemid 23000765)
354. Pinto L. Canary P, Araujo C, Bacelar S, Souhami L. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1991: 21: 557-62. (C2/112)
355. Sanchiz F. Mill A. Torner J, et al. Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys 1990; 19: 1347-50. (C1/859)
356. Cox J, Pajak T. Marcial V. et al. Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology Group protocol 83-13. Int J Radiat Oncol Biol Phys 1990: 18: 515-21. (C1/237) (Pubitemid 20129625)
357. Cox JD, Pajak TF, Marcial VA, et al. Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. Cancer 1992: 69: 1744-8. (C2/233)
358. Marcial V, Pajak T, Chang C, Tupchong L, Stetz J, tlyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity. pharynx. larynx, and sinuses. using radiation therapy as the only planned modality. Int J Radiat Oncol Biol Phys 1987; 13: 41-7. (C2/210) (Pubitemid 17029090)
359. Wang C, Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx. Cancer 1989: 63: 2461-7. (R2/60) (Pubitemid 19152756)
360. McGinn CJ, Harari PM, Fowler JF, Ford CN. Pylc GM. Kinsella TJ, Dose intensification in curative head and neck cancer radiotherapy -linear quadratic analysis and preliminary assessment of clinical results. Int J Radiat Oncol Biol Phys 1993; 27: 363-9. (P2/40) (Pubitemid 23304463)
361. Begg A. Hofland I, Van Glabekke M. Bartelink H, Horiot J. Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC Cooperative Trial 22851. Sem Radiat Oncol 1992: 1: 22-5. (C2/85)
362. Awwad H, Khafagy Y, Barsoum M, et al. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumour proliferation. Radiother Oncol 1992; 25: 261 -6. (C2/56) (Pubitemid 23000768)
363. Trotti A, Klotch D, Endicott J, Ridley M, Greenberg H. A prospective trial of accelerated radiotherapy in the postoperative treatment of high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1993: 26: 13-21. (P3/32) (Pubitemid 23137883)
364. Kaanders JHA, van Daal WAJ, Hoogenraad WJ, van der Kogel AJ, Accelerated fractionation radiotherapy for laryngeal cancer. acute. and late toxicity. Int J Radiat Oncol Riol Phys 1992; 24: 497-503. (P2/58)
365. Wang C, Blitzer P, Twice-a-day radiation therapy for cancer of the head and neck. Cancer 1985: 55: 2100-4. (RI/331) (Pubitemid 15119173)
366. Wang C, Suit H, Blitzer P, Twice-a-day radiation therapy for supraglottic carcinoma. Int J Radiat Oncol Biol Phys 1986: 12: 3-7. (R2/106) (Pubitemid 16180209)
367. Olmi P, Cellai E. Chiavacci A, Fallai C, Accelerated fractionation in advanced head and neck cancer: results md analysis of late sequele. Radiother Oncol 1990: 17: 199-207. (R2/161) (Pubitemid 20110267)
368. Ang K. Peters L. Weber R. Maor M. Morrison W, Wendt C. Brown B. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and niisopharynx. Int J Radiat Oncol Biol Phys 1990; 19: 1339-45. (P2/82)
369. Schmidt-Ullrich R, Johnson C, Wazer D. Masko G. Chasin W, Karmody C, Accelerated superfractionated irradiation for advanced carcinoma of the head and neck: concomitant boost technique. Int J Radiat Oncol Biol Phys 1991: 21: 563-8. (R2/94)
370. Harrison L, Pfister D. Fass D. et al. Concomitant chemotherapy-radiation therapy followed by hyperfracticmated radiation therapy for advanced unresectable head and neck cancer. Int J Radiat Oncol Biol Phys 1991: 21: 703 8. (P1/22)
371. Skoczylas J, Bujko K, Hliniak A. Osmolski A. Concomitant boost radiotherapy of supraglottic cancer - preliminary results, morbidity. Neoplasma 1992; 39: 119-22. (P3/42)
372. Johnson CR, Schmidt-Ullrich RK, Wazer DE. Concomitant boost technique using accelerated superfractionated radiation therapy for advanced squamous cell carcinoma 01' the head and neck. Cancer 1992: 69: 2749-54. (P1/100)
373. van den Bogaert W, Van der Schueren E. Horiot J-C, et al. EORTC Cooperative Group of Radiotherapy: Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1986: 12: 587-91. (C2/583) (Pubitemid 16081620)
374. Paris KJ, Spanos WJ, Lindberg RD. Jose B. Albrink F. Phase 1-11 study of multiple daily fractions for palliation of advanced head and neck malignancies. Int J Radiat Oncol Biol Phys 1993; 25: 657-60. (P2/37) (Pubitemid 23099259)
375. Saunders M, Dische S, Grosch E. Fermont D. Ashford R. Maher E, Makepeace A. Experience with CHART. Int J Radiat Oncol Biol Phys 1991: 71: 871-8. (R1/163)
376. Lindup R. Multiple fractions in the treatment of head and neck cancer. Clin Oncol 1992; 4: 280-3. (P3/58)
377. Wong C, Van Dyk J, Simpson W, Myelopathy following hyperfractionated accelerated radiotherapy for anaplastic thyroid carcinoma. Radiother Oncol 1991; 20: 3 - 9. (R3/32)
378. Dische S, Accelerated treatment and radiation myelitis. Radiother Oncol 1991 : 20: 1 - 2. ( 02)
379. Crellin RP, Macmillan CH. Berridge JK. Morgan DAL. Multiple fractions daily for head and neck cancer: Spinal cord effects and other late rcsults. Clin Oncol 1993; 5: 139-41. (R2/65)
380. Cox J, Pajak T. Marcial V, Coia L. Mohiuddin M, Fu K. Selim H, Rubin P, Ortiz H. ASTRO plenary: lnterfraction interval is a major determinant of late effects with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: Results from Radiation Therapy Oncology Group protocol 8313. Int J Radiat Oncol Biol Phys 1991; 20: 1191-5. (C1/479)
381. Prades J, Schmitt T. Perron X. Puel G. Martin C, Radiotherapie per operatoire et cancer de la base de langue. Technique, indications ct resultats preliminary. Ann Otolaryngol Chir Cervicofac 1989: 106: 561 5. (O2) (Pubitemid 20068719)
382. Schmitt T, Puel G. Prades J, Barbet N. Perron X. Mere P. Intraoperative radiotherapy ( IORT) for locally advanced carcinoma of the base of the tongue Technique-preliminary results. Ann Radiol ( Paris) 32: 505-8. ( P3/15)
383. Garrett P, Pugh N. Ross D. Hamaker R. Singer M. Intraoperativc radiation therapy for advanced or recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 1987: 13: 785- X. ( P2/28 ) (Pubitemid 17071658)
384. Al-Sarraf M. Chemotherapy strategies in squamous cell carcinoma of the head and neck. Crit Rev Oncol Hematol 1984: I : 323-55. (L1)
385. Martin M. Hazan A. Vergnes L. et al. Randomized study of 5-fluorouracil and cisplatin as neoadjuvant therapy in head and neck cancer: A preliminary report. Int J Radiat Oncol Biol Phys 1990: 19: 973 -5. (C3/75) (Pubitemid 20345168)
386. Kaasa S, Thorud E. Tausjö J, Wist E. Evensen J, Gundersen S, Höst H. Phase I/11 study of carboplatin and 5-fluorouracil in patients with advanced head and neck carcinoma. Eur J Cancer 1991: 77: 576 9. (P21SY)
387. Grégoire V. Beauduin M. Huniblet Y. et al A phase I-II trial of induction chemotherapy with carboplatin and fluorouracil i n locally advanced head and neck squamous cell carcinoma: A report from the UCL-Oncololgy Group. Belgium. J Clin Oncol 1991: 9: 1385 92. (R3/83)
388. Volling P, Staar S, Achterrath W, Müller R-P, Carboplatin plus radiation therapy in head and neck cancer. Semin Oncol 1991: 18(1) Suppl 2: 17 21. (P3/24)
389. Forastiere A. Chemotherapy of head and neck cancer. Ann of Oncol 1997: 3:11-4. (L2)
390. Tennvall J, Albertsson M, Biörklund A, et al. Induction chemotherapy (cisplatin + 5-fluorouracil) and radiotherapy in advanced squamous cell carcinoma of the head and neck. Acta Oncol 1991; 30: 27-32. (P2/58)
391. Klima A, Klippstein T, Bergmann L, Szepesi S, v Ilberg C. Adjuvant chemotherapy in stage III and IV squamous cell carcinoma of the head and neck. J Laryngol Otol 1988; 102: 337-40. (C3/80)
392. Recondo G, Cvitkovic E, Azli N, et al. Neoadjuvant chemotherapy consisting of cisplatin and continuous infusions of bleomycin and 5-fluorouracil for advanced head and neck cancer. Cancer 1991; 68: 2109-19. (P2/54)
393. Mazeron J-J, Martin M, Brun B, et al. Induction chemotherapy in head and neck cancer: Results of a phase III trial. Head Neck 1992; 14: 85-91. (C2/116)
394. Calais G, Reynaud-Bougnoux A, Garand G, Beutter P, Le Floch O. Oropharynx carcinoma: irradiation alone versus induction chemotherapy plus irradiation-5 year results. Br J Radiol 1990; 63: 340-5. (R2/205) (Pubitemid 20158027)
395. Richard J, Kramar A, Molinari R, et al. Randomised EORTC Head and Neck Cooperative Group trial of preoperative intra-arterial chemotherapy in oral cavity and oropharynx carcinoma. Eur J Cancer 1991; 27: 821-7. (C2/222)
396. The Department of Veterans Affairs Laryngeal Group, Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324: 1685-90. (C1/332)
397. Depondt J, Gehanno P, Martin M, et al. Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer. Oncol 1993; 50: 23-7. (C2/300) (Pubitemid 23343948)
398. Karp D, Vaughan C, Carter R, et al. Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer. A long-term follow-up report. Am J Clin Oncol 1991
399. Price LA, Shaw HJ, Hill BT. Larynx preservation after initial non-cisplatin containing combination chemotherapy plus radiotherapy, as opposed to surgical intervention with or without radiotherapy in previously untreated advanced head and neck cancer: final analysis after 12 years follow-up. J Laryngol Otol 1993; 107: 211-6. (R2/73) (Pubitemid 23151730)
400. Nikolaou A, Fountzilas G, Kosmidis P, Banis C, Sobolos K, Daniilidis J, Laryngeal preservation in cases of advanced laryngeal cancer treated with platinum based induction chemotherapy before local treatment. J Laryngol Otol 1991; 105: 930-3. (P2/28)
401. Pfister D, Strong E, Harrison L, et al. Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer. J C1in Oncol 1991; 9: 850-9. (P2/40)
402. Wolf GT, Fisher SG. Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation. Laryngoscope 1992; 102: 934-9. (C2/92)
403. Hill B, Price L. The role of adjuvant chemotherapy in the treatment of advanced head and neck cancer. Acta Oncol 1990; 29: 695-703. (L2) (Pubitemid 20354516)
404. Taylor S, Integration of chemotherapy into the combined modality therapy of head and neck squamous cancer. Int J Radiat Oncol Biol Phys 1987; 13: 779-83. (L2)
405. Gupta N, Pointon C, Wilkinson P, A randomized clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer. Clin Radiol 1987; 38: 575-81. (C2/313)
406. Bachaud J-M, David J-M, Boussin G, Daly N. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial. Int J Radiat Oncol Biol Phys 1991; 20: 243-6. (C3/83)
407. Macmillan C, Carrick K, Bradley P, Morgan D. Concomitant chemo/radiotherapy for advanced carcinoma of the head and neck. Br J Radiol 1991; 64: 941-6. (P3/25)
408. Marcial V, Pajak T, Mohiuddin M, et al. Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Cancer 1990; 66: 1861-8. (P1/124)
409. Vikram B, Malamud S, Gold J, et al. Chemotherapy rapidly alternating with accelerated radiotherapy for advanced carcinomas of the hypopharynx and upper esophagus: a feasibility study. Head Neck 1991; 13: 415-9. (P3/19)
410. Hirsch S, Caldarelli D, Hutchinson J, et al. Concomitant chemotherapy and split-course radiation for cure and preservation of speech and swallowing in head and neck cancer. Laryngoscope 1991; 101: 583-6. (R3/29)
411. Dobrowsky W, Dobrowsky E, Strassl H. Braun O, Gritzmann N, Scheiber V. Combined modality treatment of advanced cancers of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 1991; 20: 239-42. (P2/70)
412. Haraf D, Vokes E, Panje W, Weichselbaum R. Survival and analysis of failure following hydroxyurea 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer. Am J Clin Oncol 1991; 14: 419-26. (P3/39)
413. Fietkau R, Iro H, Grabenbauer G, Altendorf-Hofmann A, Sauer R. Simultane Radio-/Chemotherapie mit Cisplatin und 5-Fluorouracil bei fortgeschrittenen Kopf-Hals-Tumoren. Strahlenther Onkol 1991; 167: 693-700. (P3/47)
414. Zamboglou H, Pape T, Schnabel R, Wurm R, Bannach B, Fiirst G, Schmitt G. Kombinierte Radiotherapie mit Cisoder Carboplatin bei fortgeschrittenen Kopf-Hals-Tumoren. Strahlenther Onkol 1989; 165: 647-65. (R2/111)
415. Fu K, Phillips T, Silverberg I, et al. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial. J Clin Oncol 1987; 5: 1410-8. (C2/96) (Pubitemid 18049877)
416. Vermund H, Kaalhus O, Winther F, Transjö J, Thorud E, Harang R. Bleomycin and radiation therapy in squamous cell carcinoma of the upper aero-digestive tract: a phase III clinical trial. Int J Radiat Oncol Biol Phys 1985; 11: 1877-86. (C2/222) (Pubitemid 16195114)
417. Merlano M, Corvo R, Margarino G, et al. Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. Cancer 1991; 67: 915-21. (C2/116)
418. Keane TJ, Cummings BJ, O'Sullivan B, et al. A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma. Int J Radiat Oncol Biol Phys 1993; 25: 613-8. (C2/212) (Pubitemid 23099253)
419. Salvajoli JV, Morioka H, Trippe N, Kowalski LP, A randomized trial of neoadjuvant vs concomitant chemotherapy vs radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 1992; 249: 21 1-5. (C3/90)
420. Tupchong L, Brodovsky H, Rose L, Lowry L. Phase I/II study of hyperfractionated chemoradiotherapy ( HFRT-CX) for advanced inoperable head and neck carcinoma. Proc Ann Meet Am SOC Clin Oncol 1991; 10: A689. (P3/19)
421. Crispino S, Personeni A, Taino R. et al. Radiotherapy (RT) and concomitant plus adjunctive cisplatinum (P) and 5- fluorouracil (F) in locally advanced squamous cell carcinoma of the oropharynx. Eur Cancer News 1992; 5: 8. (P3/25)
422. Merlano M. Vitale V, Rosso R, et al. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. New Engl J Med 1992: 327: 1115-21. (C2/157)
423. Stell P, Rawson N. Adjuvant chemotherapy in head and neck cancer. Br J Cancer 1990. 61: 779-87. (M2) (Pubitemid 20151352)
424. Tannock I. Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol 1989; 16: 83-101. (L2) (Pubitemid 19258947)